SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9255Very interesting. The board is right as SNY is not stupid and will not run a trkenhott-1/31/2006
9254Harold, L Q4 revenues at $145mm, which gives effect to 6 weeks of product in thequidditch-1/31/2006
9253Well then my guess is Sanofi will be looking at a 6-hour endpoint which should mrkrw-1/31/2006
9252Mark A. Varney, Ph.D. Named Chief Operating Officer and Chief Scientific OfficerIcebrg-1/31/2006
9251They have a 6 hour label and it was cherry-picked and wasn't even significanRobohogs-1/31/2006
9250That's something to look at. Like nbix it's possible sanofi could try torkrw-1/31/2006
9249Also, what dosages will be used? O'Shea just said that 53% of scrips are noquidditch-1/31/2006
9248I'm listening to the crxx analyst day, what I've looked at as a potentiarkrw-1/31/2006
9247Most interesting (to me) in the CC so far is that Corey Davis asked why Sanofi wRocky9-1/31/2006
9246Now that we all know the pattern, will it continue in future quarters. The pattRobohogs-1/31/2006
9245gs squibb: <<Bottom line: Solid quarter, positive guidance, Buy. Sepracorquidditch-1/31/2006
9244Go Jon, Go! eomfred hayes-1/31/2006
9243quid, Lunesta all by itself is running at $700m now and if Xopenex inhalation aHarold Engstrom-1/31/2006
9242Nice call!!!rkrw-1/31/2006
9241For me, the most compelling story of the cc will be the breakout of revenue guidquidditch-1/31/2006
9240I only have one question: Does this mean that attycpa will stop posting about hRobohogs-1/31/2006
9239Congratulations to all.... Sepr up about $4 in premarket, which as we all know, Iamarangerboy-1/31/2006
92384Q05 sales $311m and $.32 per share earnings. L annual run rate at $580m. Fokenhott-1/31/2006
9237Profit for year, $0.30+ for quarter, Xopenex numbers beyond belief, Xop MDI at $Robohogs-1/31/2006
9236I'm sorry to report that I bought a few calls today. Given my recent track CrazyPete-1/30/2006
9235would have had a better feeling if you sold short ;-)Iamarangerboy-1/30/2006
9234I just added more today. Good luck all! JonRobohogs-1/30/2006
9233would like to hear that they are developing an R-formoterol/ steroid combinationIamarangerboy-1/30/2006
9232Much more interested in annual guidance for Lunesta and MDI. And expense guidancRocky9-1/30/2006
9231Actually numbers: Lunesta 117,687; Xopenex MDI 3,346Rocky9-1/30/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News